KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Payables (2016 - 2025)

Bausch Health Companies (BHC) has disclosed Payables for 17 consecutive years, with $600.0 million as the latest value for Q4 2025.

  • Quarterly Payables rose 1.87% to $600.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $600.0 million through Dec 2025, up 1.87% year-over-year, with the annual reading at $600.0 million for FY2025, 1.87% up from the prior year.
  • Payables hit $600.0 million in Q4 2025 for Bausch Health Companies, down from $616.0 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $719.0 million in Q4 2023 to a low of $342.0 million in Q1 2021.
  • Historically, Payables has averaged $548.2 million across 5 years, with a median of $565.0 million in 2023.
  • Biggest five-year swings in Payables: dropped 22.97% in 2021 and later surged 38.0% in 2023.
  • Year by year, Payables stood at $407.0 million in 2021, then grew by 28.01% to $521.0 million in 2022, then skyrocketed by 38.0% to $719.0 million in 2023, then dropped by 18.08% to $589.0 million in 2024, then grew by 1.87% to $600.0 million in 2025.
  • Business Quant data shows Payables for BHC at $600.0 million in Q4 2025, $616.0 million in Q3 2025, and $627.0 million in Q2 2025.